Prognostic models for cardiovascular and kidney outcomes in people with type 2 diabetes: living systematic review and ...

Immunity debt,” a theory to explain the global surge in non-covid infections since pandemic restrictions were lifted, is ...

Symptoms should be prioritised ahead of testing A societal transformation of attitudes and beliefs surrounding menopausal hormone therapy (MHT) has outpaced provider education, leaving primary care ...

Experts are concerned by claims—including possible future treatments for autism and diabetes—made about the value of banking baby teeth. Emma Wilkinson reports Video 1 Journalist Emma Wilkinson joins ...

The US Food and Drug Administration has approved the weight loss drug semaglutide, marketed as Wegovy, for the treatment of patients with a severe form of liver disease called metabolic associated ...

Maternity and neonatal care services are badly in need of an overhaul at national level to improve safety locally, the Health Services Safety Investigations Body (HSSIB) has warned in a review. The ...

Italy’s health minister has appointed two doctors with anti-vaccine views as advisers on immunisation policy, sending shockwaves through the country’s scientific community. The minister of health, ...

Doctors could soon be offering sodium-glucose cotransporter-2 (SGLT-2) inhibitors as a first line treatment option for all patients with diabetes, not just those with heart disease.1 The change has ...

The American Academy of Paediatrics (AAP) has issued its own childhood vaccination schedule, including a recommendation for children to receive the covid-19 vaccine, in a major split with the US ...

More than half a million people in Gaza are now “trapped in famine,” as food and clean water continue to be used as weapons of war as part of Israel’s “genocidal campaign,” aid agencies have said. The ...

Recent years have seen the emergence of research integrity sleuths, who devote time to detecting misconduct in academic research publications, a major source of which comes from paper mills, ...

A new multimillion pound programme to test new obesity services and treatments, funded in part by the weight loss drug manufacturer Eli Lilly, could be seen as “marketing by another name,” public ...